Physician profile
Justin H Townsend
NPI 1922299114
$40,336.51
in general payments reported to CMS, 2019-2025
7 companies · $14K in 2025
The $14K reported for 2025 was more than what 92% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,684 · 2021: $4,125 · 2022: $1,738 · 2023: $349 · 2024: $15K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $11K · Food and Beverage: $1,425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,060.00 |
| Travel and Lodging | $11,305.27 |
| Food and Beverage | $1,424.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $24,092.36 | 2022-2025 | Surgical Misc, Stellaris, Envista Aspire Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $8,808.78 | 2019-2021 | |
| Genentech USA, INC. | $3,737.35 | 2022-2024 | Vabysmo, Susvimo |
| Beaver-Visitec International, INC. | $2,000.00 | 2024 | |
| Genentech, INC. | $1,410.00 | 2025 | Vabysmo, Susvimo |
| Alcon Vision LLC | $166.18 | 2024-2025 | Constellation, Unity |
| Regeneron Healthcare Solutions, INC. | $121.84 | 2023 | Eylea Hd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Townsend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.